Hansa Biopharma AB Financial Overview
Hansa Biopharma AB's market cap is currently kr3.40B. The company's EPS TTM is kr-1.75; its P/E ratio is -3.14; Hansa Biopharma AB is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is kr-1.66. See an overview of income statement, balance sheet, and cash flow financials.
